We are live on ! Find out more
GC

Grace Capital Portfolio holdings

AUM $168M
1-Year Est. Return 21.6%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
AUM
$262M
AUM Growth
+$74.2M
Cap. Flow
+$60.4M
Cap. Flow %
23.06%
Top 10 Hldgs %
27.97%
Holding
236
New
148
Increased
23
Reduced
45
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 19.43%
2 Technology 18.17%
3 Financials 14.51%
4 Consumer Discretionary 9.11%
5 Energy 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GERN icon
201
Geron
GERN
$924M
$55K 0.02%
+16,000
New +$61.1K
STON
202
DELISTED
StoneMor Inc.
STON
$53K 0.02%
+8,700
New +$52.7K
RDY icon
203
Dr. Reddy's Laboratories
RDY
$10.4B
$48K 0.02%
+5,000
New +$31.5K
FTV icon
204
Fortive
FTV
$18.6B
$39K 0.01%
+793
New +$37.9K
TAR
205
DELISTED
TELEFONICA DE ARGENTINA SA ADS (40 CL-B) (NEW)
TAR
$39K 0.01%
+4,520
New +$39K
XLE icon
206
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
$38K 0.01%
+1,000
New +$37.2K
TEVA icon
207
Teva Pharmaceuticals
TEVA
$36.1B
$36K 0.01%
+1,500
New +$30.6K
BAX icon
208
Baxter International
BAX
$11.4B
$30K 0.01%
+400
New +$28.2K
DGRO icon
209
iShares Core Dividend Growth ETF
DGRO
$41.9B
$25K 0.01%
+730
New +$25.1K
ATI icon
210
ATI
ATI
$25.4B
$20K 0.01%
+800
New +$21.6K
SVC
211
Service Properties Trust
SVC
$1.13B
$20K 0.01%
+140
New +$18.9K
TRGP icon
212
Targa Resources
TRGP
$60.6B
$20K 0.01%
+403
New +$19.2K
NUE icon
213
Nucor
NUE
$52.5B
$19K 0.01%
+300
New +$19.1K
BLPH
214
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$11K ﹤0.01%
+306
New +$10.6K
ABT icon
215
Abbott
ABT
$177B
$9K ﹤0.01%
+150
New +$9.09K
EDIT icon
216
Editas Medicine
EDIT
$442M
$4K ﹤0.01%
+111
New +$3.93K
AMCX icon
217
AMC Global Media
AMCX
$462M
-22,710
Closed -$1.17M
CHKP icon
218
Check Point Software Technologies
CHKP
$14.1B
-48,305
Closed -$4.78M
CMCSA icon
219
Comcast
CMCSA
$84.9B
-81,681
Closed -$2.73M
CYRX icon
220
CryoPort
CYRX
$792M
-14,380
Closed -$117K
LECO icon
221
Lincoln Electric
LECO
$13.4B
-3,104
Closed -$277K
NGG icon
222
National Grid
NGG
$82B
-4,132
Closed -$207K
NVS icon
223
Novartis
NVS
$285B
-65,826
Closed -$4.73M
NXPI icon
224
NXP Semiconductors
NXPI
$67.5B
-3,412
Closed -$397K
PAYX icon
225
Paychex
PAYX
$41B
-5,490
Closed -$335K

Similar funds

Grace Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Grace Capital held 236 positions worth $262M, up 40% from $188M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Grace Capital deployed $60.4M of net new capital in Q2 2018, opening 148 new positions and adding to 23 existing holdings. Its largest new stake was MyoKardia, Inc. Common Stock: 177,304 shares worth $8.8M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Citigroup, an estimated $3.89M trimmed.

  • Grace Capital's largest Q2 2018 buy was MyoKardia, Inc. Common Stock: 177,304 shares worth $8.8M.
  • Grace Capital added most to Meta Platforms (Facebook) in Q2 2018, an estimated $2.91M increase.
  • Grace Capital's biggest Q2 2018 reduction was Citigroup, cutting an estimated $3.89M.
  • Grace Capital fully exited Check Point Software Technologies in Q2 2018, selling an estimated $4.78M.
  • Grace Capital's ten largest holdings make up 28% of its $262M portfolio in Q2 2018.
  • Grace Capital opened 148 new positions and closed 16 in Q2 2018.
  • Grace Capital's portfolio value rose 40% quarter-over-quarter to $262M.

Based on Grace Capital's 13F filing for Q2 2018, filed 15 Aug 2018.